Wells Fargo Maintains Equal-Weight on Amrize, Lowers Price Target to $40
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $44 to $40.
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $44 to $40.